KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 27, 2026 | xxxxxxxxxxxxx | $3691148 | |
Jul 10, 2025 | xxxxxxxxxxxxx | $517441 | |
Jul 10, 2025 | xxxxxxxxxxxxx | $474623 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $31025635 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,089,354 | Insider | 9.94% | 95,751,106 | |
| 2,808,583 | Institution | 5.48% | 52,840,681 | |
| 2,156,207 | Institution | 4.21% | 40,566,878 | |
| 1,921,092 | Institution | 3.75% | 36,143,425 | |
| 1,817,888 | Institution | 3.55% | 34,201,745 | |
| 1,777,827 | Institution | 3.47% | 33,448,037 | |
| 1,275,819 | Institution | 2.49% | 24,003,259 | |
| 451,815 | Insider | 0.88% | 8,500,447 | |
| 404,622 | Institution | 0.79% | 7,612,558 | |
| 393,433 | Institution | 0.77% | 7,402,048 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,808,583 | Institution | 5.48% | 52,840,681 | |
| 1,777,827 | Institution | 3.47% | 33,448,037 | |
| 404,622 | Institution | 0.79% | 7,612,558 | |
| 393,433 | Institution | 0.77% | 7,402,048 | |
| 322,565 | Institution | 0.63% | 6,068,738 | |
| 300,117 | Institution | 0.59% | 5,646,401 | |
| 221,538 | Institution | 0.43% | 4,168,016 | |
| 123,235 | Institution | 0.24% | 2,318,543 | |
| 115,851 | Institution | 0.23% | 2,179,621 | |
| 99,576 | Institution | 0.19% | 1,873,423 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns KalVista Pharmaceuticals (DE:4XC1)?
Currently, no data Available
What percentage of KalVista Pharmaceuticals (DE:4XC1) stock is held by institutional investors?
Currently, no data Available
What percentage of KalVista Pharmaceuticals (DE:4XC1) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of KalVista Pharmaceuticals (DE:4XC1)?
Venrock Healthcare Capital Partners III, L.P. owns the most shares of KalVista Pharmaceuticals (DE:4XC1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.